Crossmark

Fabrication and application of dimyristoyl phosphatidylcholine biomaterial-based nanocochleates dry powder inhaler for controlled release resveratrol delivery

Crossref DOI link: https://doi.org/10.1186/s43094-021-00189-4

Published Online: 2021-02-15

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mali, A. J. http://orcid.org/0000-0002-0391-1606
Joshi, P. A.

Bothiraja, C.

Pawar, A. P.
License Information

Text and Data Mining valid from 2021-02-15

Version of Record valid from 2021-02-15
More Information

Article History

Received: 15 October 2020

Accepted: 19 January 2021

First Online: 15 February 2021

Ethics approval and consent to participate

: A research proposal was prepared according to the guidelines of the Committee for the Purpose of Control and Supervision of the Experiment of Animals (CPCSEA). The experiment protocol was approved by the Institutional Animal Ethics Committee (IAEC) of Poona College of Pharmacy, Pune (CPCSEA/15/2015).

: Not applicable.

: The authors declare that they have no competing interests regarding the present work.

Document is current

Any future updates will be listed below